Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
03.12.25
/
50%
€375.90
Target price
03.12.26
€443.40
Performance (%)
2.47%
Price
12.12.25
€385.20
Summary
This prediction is currently active. With a performance of 2.47%, the BUY prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 03.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $516.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat